Steven R. Goldsmith, MD


Specialty Centers

Commitment to Patient-Centered Care

"I am committed to providing focused, individualized care to all of my patients in the context of current evidenced-based and guideline-consistent cardiology practice."

Clinical Expertise

Dr. Goldsmith has nearly 35 years of experience in general cardiology with a particular interest in heart failure.


  • Board Certified, Internal Medicine
  • Board Certified, Cardiology
  • Authored several peer-reviewed publications in leading medical journals

Professional Affiliations

  • American College of Cardiology


  • GoldsmithSR, Elkayam U, Haught WH, Barve A, He W. Efficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot Study. J. Card Fail. 2008;14(8):641-647.
  • Bank, AJ, Kaufman CL, Kelly AS, Burns, KV, Adler SW, Rector, TS, Goldsmith SR, Olivari, M-TP, Tang C, Nelson L, Metzig A. Results of the PROspective MInnesota study of ECHO/TDIi in Cardiac Resynchronization Therapy (PROMISE-CRT) Study. J Card Fail. 2009;15(5)401-409.
  • Goldsmith SR, Sobotka PA, Bart BA. The Sympathorenal Axis in Hypertension and Heart Failure. J Card Fail. 2010;16(5):369-373.
  • Felker FM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic Strategies in Patients with Acute Decompensated Heart Failure. New Engl J Med 2011;364(9):797-805.
  • Ambrosy A, Goldsmith SR, Gheorghiade M. Tolvaptan for the Treatment of Heart Failure: A Review of the Literature. Expert Opin Pharmacother. 2011;12(6):961-976.
  • Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic Strategies in Patients with Acute Decompensated Heart Failure. N Engl J Med. 2011;364(9):797-805.
  • Goldsmith SR, Gilbertson DT, Mackedanz SA, Swan SK. Renal Effects of Conivaptan, Furosemide, and the Combination in Patients with Chronic Heart Failure. J Card Fail. 2011;17(12):982-989.
  • Sobotka PA, Goldsmith SR. Found in Translation. J Card Fail. 2011;17(10):804-805.
  • Bart BA, Goldsmith SR, Lee KL, Redfield MM, Felker GM, O'Connor CM. Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Rationale and Design of CARRESS-HF. J Card Fail. 2012;18(3):176-182.
  • Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, et al. Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome. N Engl J Med. 2012;367(24):2296-2304.
  • Gupta A, Braunwald E, McNulty S, Felker GM, Gilbert EM, Alharethi R, Lee KL, Anstrom KJ, Redfield MM, Goldsmith SR, et al. Obesity and the Response to Intensified Diuretic Treatment in Decompensated Heart Failure: A DOSE Trial Substudy. J Card Fail. 2012;18(11):837-844.
  • Lanfear DE, Sabbah HN, Goldsmith SR, et al. Association of Arginine Vasopressin Levels with Outcomes and the Effect of V2 Blockade in Patients Hospitalized for Heart Failure with Reduced Ejection Fraction: Insights from the EVEREST Trial. Circ Heart Fail. 2012;6:47-52.
  • Brandimarte F, Vaduganathan M, Mureddu GF, Cacciatore G, Sabbah HN, Fonarow GC, Goldsmith SR, et al. Prognostic Implications of Renal Dysfunction in Patients Hospitalized with Heart Failure: Data from the Last Decade of Clinical Investigations. Heart Fail Rev. 2013;18(2):167-176.
  • Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O’Connor CM, Felker GM, Goldsmith SR, et al. Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure with Preserved Ejection Fraction: A Randomized Clinical Trial. JAMA. 2013;309(12):1268-1277.
  • Sandoval Y, Williams DM, Goldsmith SR. Appendicitis Presenting as Cardiac
    Tamponade. J Thorac Cardiovasc Surg. 2013;146(1)228.
  • Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, et al. Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure with Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial. JAMA. 2013; 310(23):2533-2543. doi:10.1001/jama.2013.282190.
  • Kalra A, Maharaj V, Goldsmith SR. Vasopressin Receptor Antagonists: From Pivotal Trials to Current Practice. Curr Heart Fail Rep. 2014;11(1):10-18.
  • Mentz RJ, Stevens SR, DeVore AD, Lala A, Vader JM, AbouEzzeddine OF, Khazanie P, Redfield MM, Stevenson LW, O’Connor CM, Goldsmith SR, Bart BA, Anstrom KJ, Hernandez AF, Braunwald E, Felker GM. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. JACC: Heart Failure. 2015;3(2):97-107.
  • Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J, Tang WH, Dunlap ME, LeWinter MM, Mann DL, Felker GM, O’Connor CM, Goldsmith SR, et al. for the NHLBI Heart Failure Clinical Research Network. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The EXACT-HF Study. Circulation. 2015;131(20):1763-1771.
  • Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF, DeVore AD, Khazanie P, Redfield MM, Goldsmith SR, Bart BA, Anstrom KJ, Felker GM, Hernandez AF, Stevenson LW. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circ Heart Fail. 2015;8(4):741-748.

Medical School

Ohio State University, Columbus, OH, USA


Internal Medicine, Ohio State University, Columbus, OH, USA


Cardiology, University of Minnesota, Minneapolis, MN, USA